Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Leukemia
|
March 21, 2018
Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tsewang Tashi, Sabina Swierczek, Soo Jin Kim, et al.
Annals of Hematology
|
January 13, 2025
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, et al.
Blood Advances
|
January 26, 2026
Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant MPN patients
Tsewang Tashi, Lee-Yung Shih, Yi-Te Yo, et al.
Journal of Palliative Medicine
|
September 1, 2011
Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population
Wilson I Gonsalves, Tsewang Tashi, Jairam Krishnamurthy, et al.
Blood Cancer Discovery
|
May 24, 2021
Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Julie E Feusier, Sasi Arunachalam, Tsewang Tashi, et al.
Journal of Surgical Oncology
|
February 22, 2011
Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis
Wilson I Gonsalves, Swapna Kanuri, Tsewang Tashi, et al.
Oncotarget
|
December 31, 2016
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer
Lucie Lanikova, N Scott Reading, Hao Hu, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 25, 2017
Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders
Tsewang Tashi, N Scott Reading, Tanna Wuren, et al.
Current Hematologic Malignancy Reports
|
July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms
Prithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Plos Genetics
|
April 28, 2017
Evolutionary history of Tibetans inferred from whole-genome sequencing
Hao Hu, Nayia Petousi, Gustavo Glusman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Leukemia
|
March 21, 2018
Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tsewang Tashi, Sabina Swierczek, Soo Jin Kim, et al.
Annals of Hematology
|
January 13, 2025
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, et al.
Blood Advances
|
January 26, 2026
Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant MPN patients
Tsewang Tashi, Lee-Yung Shih, Yi-Te Yo, et al.
Journal of Palliative Medicine
|
September 1, 2011
Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population
Wilson I Gonsalves, Tsewang Tashi, Jairam Krishnamurthy, et al.
Blood Cancer Discovery
|
May 24, 2021
Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Julie E Feusier, Sasi Arunachalam, Tsewang Tashi, et al.
Journal of Surgical Oncology
|
February 22, 2011
Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis
Wilson I Gonsalves, Swapna Kanuri, Tsewang Tashi, et al.
Oncotarget
|
December 31, 2016
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer
Lucie Lanikova, N Scott Reading, Hao Hu, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 25, 2017
Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders
Tsewang Tashi, N Scott Reading, Tanna Wuren, et al.
Current Hematologic Malignancy Reports
|
July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms
Prithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Plos Genetics
|
April 28, 2017
Evolutionary history of Tibetans inferred from whole-genome sequencing
Hao Hu, Nayia Petousi, Gustavo Glusman, et al.
Page
of 4